Literature DB >> 17666659

Uterine carcinosarcoma associated with hereditary nonpolyposis colorectal cancer.

Stacey A South1, Mollie Hutton, Carolyn Farrell, Paulette Mhawech-Fauceglia, Kerry J Rodabaugh.   

Abstract

BACKGROUND: Hereditary nonpolyposis colorectal cancer (HNPCC) was originally described as a genetic disorder predominantly involving colorectal cancer. Numerous neoplasms are known to be associated with this condition. Sarcomas have also been reported within families with HNPCC. The challenge is determining if these cancers are sporadic or hereditary. CASE: We report on a 46-year-old woman with uterine carcinosarcoma and a family history suspicious for HNPCC. Genetic testing identified a germline MLH1 mutation. Immunohistochemistry testing of the carcinosarcoma revealed loss of MLH1 expression with preservation of MSH2 expression.
CONCLUSION: The loss of MLH1 protein expression suggests the germline mutation contributed to the development of the carcinosarcoma. Hereditary nonpolyposis colorectal cancer should be included in the differential diagnosis of persons with uterine carcinosarcoma when noted within a family history suspicious for HNPCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666659     DOI: 10.1097/01.AOG.0000275262.60526.01

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

Review 1.  Review of Recommended Treatment of Uterine Carcinosarcoma.

Authors:  Joseph Menczer
Journal:  Curr Treat Options Oncol       Date:  2015-11

2.  Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum.

Authors:  Mef Nilbert; Christina Therkildsen; Anja Nissen; Måns Akerman; Inge Bernstein
Journal:  Fam Cancer       Date:  2009-01-08       Impact factor: 2.375

3.  Uterine Corpus Malignancies in Appalachia Kentucky: Incidence, Survival, and Related Health Disparities.

Authors:  Marian Symmes Johnson; Thomas C Tucker; Quan Chen; Bin Huang; Christopher P DeSimone; Rachel W Miller; Lauren A Baldwin; Tricia I Fredericks; Brian T Burgess; Frederick R Ueland
Journal:  South Med J       Date:  2020-01       Impact factor: 0.954

4.  Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes.

Authors:  Siân Jones; Nicolas Stransky; Christine L McCord; Ethan Cerami; James Lagowski; Devon Kelly; Samuel V Angiuoli; Mark Sausen; Lisa Kann; Manish Shukla; Rosemary Makar; Laura D Wood; Luis A Diaz; Christoph Lengauer; Victor E Velculescu
Journal:  Nat Commun       Date:  2014-09-19       Impact factor: 14.919

5.  Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum.

Authors:  Rein P Stulp; Johanna C Herkert; Arend Karrenbeld; Bart Mol; Yvonne J Vos; Rolf H Sijmons
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

6.  Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium.

Authors:  Yiying Wang; Yue Wang; Jie Li; Janiel Cragun; Kenneth Hatch; Setsuko K Chambers; Wenxin Zheng
Journal:  J Hematol Oncol       Date:  2013-03-25       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.